Some CBD products and companies allegedly use unsubstantiated claims about the ability of CBD to treat health conditions to promote their products. These claims include the ability to treat chronic pain, diabetes, glaucoma, cancer, and other chronic illnesses. Many of these products also claim to treat mental illnesses, such as anxiety, depression, ADHD, PTSD, and others. However, the FDA issued warning letters in December 2020, some of which noted that certain methods of CBD consumption may even be dangerous to users.
In a letter to the President of G & L Wellness, LLC, the FDA Director of the Office of Compliance wrote that the company’s CBD eyedrops were unapproved as drugs and were “especially concerning from a public health perspective because ophthalmic drug products can pose serious risk of harm to humans and/or animals if toxic substances are introduced directly into the eye because irreversible damage, including vision loss, can result.”
Similarly, the FDA warned a company called New Leaf Pharmaceuticals, LLC that its CBD nasal spray products were “especially concerning from a public health perspective because intranasal drug products may be rapidly absorbed through the highly vascularized nasal mucosa directly into systemic blood circulation, where they may exert undesirably systemic effects such as increased heart rate or elevated blood pressure. If toxic substances are introduced directly into the nose, harmful local effects such as bleeding, ulceration, or nasal septal perforation may occur.”
Some of these products include, but are not limited to:
- C Better Daily Adult Regular Formula eyedrops
- C Better Daily Adult Maximum Formula eyedrops
- C Better Daily Soothing Formula eyedrops
- reLeaves 40 mg CBD Pet Shampoo
- reLeaves Full-Spectrum CBD Dried Dog Treat Cookies
- reLeaves CBD Broad Spectrum Tincture
- WBRx Metered-Dose Inhaler
- WBRx Balance Softgels CBD
- WBRx Pure Wellness CBD
- WBRx Combo Pack
- WBRx Energy Oil Drops CBD
- WBRx Relief Balm CBD
- WBRx Sleep
- Canna Bees Rescue Blend
Attorneys at Finkelstein, Blankinship, Frei-Pearson & Garber, LLP have successfully recovered millions of dollars on behalf of victims of false advertising and other wronged consumers. We are currently investigating this matter, as well as other false advertising and products liability matters. If you believe that you bought any of these CBD products and/or were misled, please contact us to discover your legal actions.